Monteys AM - Search Results

1

Regulated control of gene therapies by drug-induced splicing.

Monteys AM, Hundley AA, Ranum PT, Tecedor L, Muehlmatt A, Lim E, Lukashev D, Sivasankaran R, Davidson BL. Monteys AM, et al. Nature. 2021 Aug;596(7871):291-295. doi: 10.1038/s41586-021-03770-2. Epub 2021 Jul 28. Nature. 2021. PMID: 34321659 Free PMC article.

2

Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs.

Boudreau RL, Monteys AM, Davidson BL. Boudreau RL, et al. Among authors: monteys am. RNA. 2008 Sep;14(9):1834-44. doi: 10.1261/rna.1062908. Epub 2008 Aug 12. RNA. 2008. PMID: 18697922 Free PMC article.

3

Structure and activity of putative intronic miRNA promoters.

Monteys AM, Spengler RM, Wan J, Tecedor L, Lennox KA, Xing Y, Davidson BL. Monteys AM, et al. RNA. 2010 Mar;16(3):495-505. doi: 10.1261/rna.1731910. Epub 2010 Jan 14. RNA. 2010. PMID: 20075166 Free PMC article.

4

Singles engage the RNA interference pathway.

Davidson BL, Monteys AM. Davidson BL, et al. Among authors: monteys am. Cell. 2012 Aug 31;150(5):873-5. doi: 10.1016/j.cell.2012.08.008. Cell. 2012. PMID: 22939614 Free article.

5

Single nucleotide seed modification restores in vivo tolerability of a toxic artificial miRNA sequence in the mouse brain.

Monteys AM, Spengler RM, Dufour BD, Wilson MS, Oakley CK, Sowada MJ, McBride JL, Davidson BL. Monteys AM, et al. Nucleic Acids Res. 2014 Dec 1;42(21):13315-27. doi: 10.1093/nar/gku979. Epub 2014 Oct 20. Nucleic Acids Res. 2014. PMID: 25332397 Free PMC article.

6

Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.

Lee JH, Tecedor L, Chen YH, Monteys AM, Sowada MJ, Thompson LM, Davidson BL. Lee JH, et al. Among authors: monteys am. Neuron. 2015 Jan 21;85(2):303-15. doi: 10.1016/j.neuron.2014.12.019. Epub 2014 Dec 31. Neuron. 2015. PMID: 25556834 Free PMC article.

7

Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In Vivo.

Monteys AM, Wilson MJ, Boudreau RL, Spengler RM, Davidson BL. Monteys AM, et al. Mol Ther Nucleic Acids. 2015 Apr 7;4:e234. doi: 10.1038/mtna.2015.7. Mol Ther Nucleic Acids. 2015. PMID: 25849618 Free article.

8

PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington's Disease-Associated Phenotypes In Vivo.

Ochaba J, Monteys AM, O'Rourke JG, Reidling JC, Steffan JS, Davidson BL, Thompson LM. Ochaba J, et al. Among authors: monteys am. Neuron. 2016 May 4;90(3):507-20. doi: 10.1016/j.neuron.2016.03.016. Epub 2016 Apr 14. Neuron. 2016. PMID: 27146268 Free PMC article.

9

CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo.

Monteys AM, Ebanks SA, Keiser MS, Davidson BL. Monteys AM, et al. Mol Ther. 2017 Jan 4;25(1):12-23. doi: 10.1016/j.ymthe.2016.11.010. Epub 2017 Jan 4. Mol Ther. 2017. PMID: 28129107 Free PMC article.

10

Author Correction: Regulated control of gene therapies by drug-induced splicing.

Monteys AM, Hundley AA, Ranum PT, Tecedor L, Muehlmatt A, Lim E, Lukashev D, Sivasankaran R, Davidson BL. Monteys AM, et al. Nature. 2022 Feb;602(7897):E25. doi: 10.1038/s41586-021-04366-6. Nature. 2022. PMID: 35105975 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters